Cheddar is partnering with StackCommerce to bring you the Cheddar Shop. This article doesn’t constitute editorial endorsement, and we earn a portion of all sales.

Wall Street can be a ruthless environment for the uninitiated, but learning how to invest responsibly can be extremely lucrative, especially if you become a day trader. Don’t quit your day job just yet though. In order to be a successful professional trader, you need to learn the tools of the trade (pun intended.)

If you’re interested in pursuing stock trading as a side hustle or a full-time venture, The Wall Street Survival & Stock Trading Guide Bundle can help. It features 8 comprehensive courses that will teach you technical and fundamental analysis techniques that the average consumer with a modest stock portfolio wouldn't know. These courses offer a wealth of knowledge normally at $200 apiece, but you can get this entire bundle today for $29.99

Newcomers to the stock market and investing, in general, should head over to The Complete Stock Market Investing Guide for Beginners first. This class will introduce you to the basics of stock investing such as setting up your investment account and finding your first successful stocks. 

If the idea of day trading still feels intimidating to you, the next training we recommend is The Beginner's Guide to Swing Trading Stocks Part-Time. You’ll learn how to profit from swing trade positions consistently, how to find the right stocks to invest in—and when to enter or exit the market.

The rest of the courses focus on day trading, which requires you to be more active in the stock market every day. These cover everything you need to know about victory in the profession, including how to minimize risk, identify chart patterns, read the tape, trade penny stocks, and much more. 

Professional trading is as risky as it is profitable, but by following the fundamentals and playing intelligently, you can turn it into a successful career. The Wall Street Survival & Stock Trading Guide Bundle retails for $1,600, but you can get all 8 courses for just $29.99 with this 98% off deal. 

Share:
More In Business
Digital Advertising Company AdTheorent to Trade Under Ticker '$ADTH'
AdTheorent just the latest company to go public via a SPAC. The company specializes in digital advertising, using AI and machine learning as a tool to move marketing forward. AdTheorent to close its SPAC merger with MCAP Acquisition today and will trade on the Nasdaq under the ticker symbol ADTH. CEO Jim Lawson spoke with Cheddar ahead of the move.
Dorsey, Musk Express Skepticism Over Blockchain-based Web3
Although still early in development, blockchain technology, Web3, also known as Web 3.0 has been getting a lot of attention from some top tech names lately. Web3 is based on blockchain technology, which powers NFT’s and cryptocurrencies such as bitcoin. With Web3, users would ideally control their own data, rather than have it be controlled by a few large companies. But, Tesla CEO Elon musk isn't buying into Web3 just yet, tweeting over the weekend that the decentralized iteration of the internet seems more like a marketing "buzzword" right now than reality. Twitter co-founder Jack Dorsey also chiming in to the conversation, expressing doubt over whether or not Web3 would actually be decentralized if ownership still belonged to venture capital firms. Parker McCurley, co-founder & CEO of Decent Labs explains the significance of Web3 catching the eye of the tech giants, and what Web3 could mean for the future of the internet.
FDA Authorizes Pfizer's Covid-19 Treatment Pill Marking Pandemic Milestone
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home. Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
TSA Numbers Stay High as the Omicron Variant Spreads
On December 20th, the TSA reported that for the fourth day in a row, it had screened more than 2 million people through its airports as the Omicron variant continues to rage and spread rapidly throughout the country. The CDC now reporting that roughly 73% of all covid cases are caused by the Omicron variant ahead of President Biden’s remarks aimed towards curbing the virus and helping hospitals battle rises in hospitalizations. Dr. Nasia Safdar breaks down the latest on traveling during the pandemic.
Markets Continue to Feel Omicron Pressures
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Load More